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Synaptic vesicles must be primed to fusion competence before they
can fuse with the plasma membrane in response to increased
intracellular Ca2 levels. The presynaptic active zone protein
Munc13-1 is essential for priming of glutamatergic synaptic vesicles
in hippocampal neurons. However, a small subpopulation of syn-
apses in any given glutamatergic nerve cell as well as all -amino-
butyratergic (GABAergic) synapses are largely independent of
Munc13-1. We show here that Munc13-2, the only Munc13 isoform
coexpressed with Munc13-1 in hippocampus, is responsible for
vesicle priming in Munc13-1 independent hippocampal synapses.
Neurons lacking both Munc13-1 and Munc13-2 show neither
evoked nor spontaneous release events, yet form normal numbers
of synapses with typical ultrastructural features. Thus, the two
Munc13 isoforms are completely redundant in GABAergic cells
whereas glutamatergic neurons form two types of synapses, one
of which is solely Munc13-1 dependent and lacks Munc13-2
whereas the other type employs Munc13-2 as priming factor. We
conclude that Munc13-mediated vesicle priming is not a transmit-
ter specific phenomenon but rather a general and essential feature
of multiple fast neurotransmitter systems, and that synaptogen-
esis during development is not dependent on synaptic secretory
activity.
Neurotransmitter release from neurons is restricted to syn-aptic active zones where the final steps of synaptic vesicle
exocytosis take place in a highly coordinated manner. Typically,
only a fraction of vesicles in close proximity of the active zone
plasma membrane is primed (fusion competent) and able to fuse
with the plasma membrane in response to an action potential and
concomitant Ca2 influx. The size of this readily releasable
vesicle pool and its dynamic regulation by the priming machinery
determine the efficacy and signaling capacity of synapses (1, 2).
The mammalian Unc-13 homologue Munc13-1 is an essential
component of the synaptic vesicle priming machinery (3). Glu-
tamatergic, hippocampal Munc13-1 knockout (KO) neurons
form morphologically normal synapses, most of which are inca-
pable of neurotransmission because their synaptic vesicles are
not fusion competent (3). Similar observations were made in
Caenorhabditis elegans and Drosophila lacking the invertebrate
Munc13-1 homologues Unc-13 or Dunc-13 (4, 5). Interestingly,
the mutant phenotype of Munc13-1 KO synapses in mouse
hippocampus is restricted to glutamatergic neurons. -Aminobu-
tyratergic (GABAergic) cells are almost completely unaffected
(3, 6). Moreover, individual glutamatergic hippocampal neurons
form two types of synapses with differential Munc13-1 depen-
dence where 90% of synapses are completely silenced in the
absence of Munc13-1 whereas the remaining synapses release
transmitter with normal probability (3, 6).
In contrast to the mouse protein, Munc13-1 homologues in C.
elegans and Drosophila show no transmitter or synapse specific
functions (4, 5). Although the genomes of these invertebrates
contain only one unc-13dunc-13 gene each, the mammalian
Munc13 family is comprised of three independent gene products
(Munc13-1, -2, and -3; refs. 7 and 8). Thus, the striking transmitter
and synapse specificity of Munc13-1 function in mouse hippocam-
pus may be caused by a redundancy with a second Munc13 isoform
that can substitute for Munc13-1 in all GABAergic and a small
subpopulation of glutamatergic synapses. Alternatively, neurons
that are not affected by Munc13-1 loss may employ a Munc13-
independent vesicle-priming mechanism.
To examine the role of other Munc13 isoforms in hippocampal
neurons, we generated KO mice lacking both splice variants of
Munc13-2 (9), the only known Munc13 isoform that is coex-
pressed with Munc13-1 in rodent hippocampus (8, 10).
Materials and Methods
Stem Cell Experiments. Munc13-2 KO mice were generated by
homologous recombination in embryonic stem cells (3, 11, 12).
In the targeting vector (Fig. 1A), a 6-kb genomic fragment
containing multiple exons of the Munc13-2 gene that are shared
by the two Munc13-2 splice variants [bp 2907–3904 of
bMunc13-2 cDNA (GenBank U24071); bp 1439–2436 of ub-
Munc13-2 cDNA (GenBank AF159706)] was replaced by a
neomycin resistance cassette. Recombinant stem cell clones were
analyzed by Southern blotting of genomic DNA digested with
EcoRI. Two of a total of three positive clones were injected into
mouse blastocysts to obtain highly chimeric mice that transmit-
ted the mutation through the germ line. Germ line transmission
of the mutations was confirmed by Southern blotting (EcoRI;
Fig. 1B). Immunoblotting of adult brain homogenates with an
antibody recognizing both Munc13-2 splice variants demon-
strated the total absence of Munc13-2 in mutant brains (Fig. 1C).
Munc13-12 double KO mice (DKO) were generated by breed-
ing and genotyped by Southern blotting, PCR, and Western
blotting (Fig. 1D).
Cell Culture, Electrophysiology, Synapse Quantification, and FM1-43
Staining. Electrophysiological experiments were performed on
individual autaptic hippocampal neurons [8–15 days in vitro
(DIV)] from wild-type and Munc13-2 KO or Munc13-2 KO and
Munc13-12 DKO littermates (13, 14). Data are expressed as
mean  SE. Significance was tested by using Student’s t test or
one-way ANOVA with the Bonferroni-Dunn procedure for
multiple comparisons (INSTAT; GraphPad Software, San Diego,
CA). Semliki Forest virus experiments were performed as
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described (9). For quantification of synapse density, neurons
were fixed and double labeled for synaptophysin and microtu-
bule-associated protein (MAP)-2. Fluorescence images were
recorded as described (6). Pixel noise in the images was reduced
by a ‘‘sharpening’’ function, followed by low pass filtering.
Synapses were distinguished from background fluorescence by
setting a threshold that shows only objects above this threshold
intensity. Objects smaller than 0.17 m2 were discarded; larger
objects were detected by an object recognition algorithm and
sorted by size. The average sized synapse was identified as the
object that appeared at the highest frequency in the image. The
proper threshold was calculated by a custom written algorithm
that analyzed an image series with varying thresholds. Optimal
threshold was determined when the total f luorescence intensity
from the objects with highest occurrence (0.53  0.14 m2, 19
images, 20.622 objects) was maximal. Objects were considered to
be synapses when their size was larger than 50% of the average
synapse size. Spots whose summed fluorescence intensity was
larger than twice the average were counted as two synapses. Data
were expressed as synapse number per m2 dendrite surface.
FM1-43 staining of active synapses was done as described (6).
Western Blotting, Histology, Electron Microscopy, and Antibodies.
Synaptic protein expression in embryonic day 18 (E18) or adult
brains was analyzed by Western blotting. For histological anal-
yses, E18 mouse pups were immersion fixed in paraformalde-
hyde. Spinal cord and brain were then cryoprotected and frozen.
Sagittal brain sections and coronal spinal cord sections (10 m)
were collected and Nissl stained. For electron microscopic
analyses, primary hippocampal cultures were processed accord-
ing to standard procedures. In brief, cultures (12 DIV) were fixed
with glutaraldehyde and embedded in Durcupan. Ultrathin
sections (55 nm) were observed in a Philips (Eindhoven, The
Netherlands) CM 120 electron microscope. Digital pictures from
synapses were taken and analyzed by using DIGITAL MICRO-
GRAPH (Gatan, Pleasanton, CA). Vesicles within 6 nm of the
active zone plasma membrane were defined as docked. The
length of the active zone was defined as the length of presynaptic
membrane facing a postsynaptic specialization. Data are ex-
pressed as mean SE. Significance was tested by using Student’s
t test and unpaired nonparametric test (Wilcoxon). All antibod-
ies were from Synaptic Systems (Go¨ttingen, Germany), except
antibodies to Munc13-2, Munc13-3, MAP-2 (Chemicon), glu-
tamic acid decarboxylase (GAD; Biotrend, Cologne, Germany),
and Rab-3-interacting molecule (RIM) (Transduction Labora-
tories, Lexington, KY).
Results
Basic Characteristics of Munc13-2 KO Mice. Munc13-2 KO mice were
generated as described above (Fig. 1 A). Southern blot analysis
of offspring obtained by interbreeding heterozygous Munc13-2
KOs showed that the respective genotypes (, , and
) were present at the expected Mendelian frequency (Fig.
1B). Munc13-2 protein expression was completely abolished in
homozygous mutants and reduced by about 50% in heterozygous
littermates (Fig. 1C). Apart from sporadic seizures in older
animals (above 12 mo of age), Munc13-2 KOs were indistin-
guishable from wild-type littermates. Brains of Munc13-2 KOs
showed a normal cell density, cytoarchitecture, connectivity,
distributiondensity of synapses, and ultrastructural morphology
(not shown). Levels of all tested synaptic proteins (Munc13-1,
soluble NSF-attachment protein (-SNAP), complexin I, com-
plexin II, Munc18-1, N-ethylmaleimide-sensitive factor (SNF),
Rab3A, synaptosome-associated protein of 25 kDa (SNAP-25),
synapsin IIIa, synapsin IIb, synaptobrevin 2, synaptophysin,
synaptotagmin I, and syntaxin 1) were unaffected by the lack of
Munc13-2 (not shown).
Properties of Munc13-2 KO and Munc13-12 DKO Neurons. Excitatory
postsynaptic currents (EPSCs) from wild-type and Munc13-2
KO neurons were not significantly different. EPSCs were 5.0 
0.8 nA (n 10) for wild-type cells and 5.2 0.8 nA (n 19) for
Munc13-2 KO cells (Fig. 2 A and B). Likewise, elimination of
Munc13-2 had no apparent effect on inhibitory synaptic trans-
mission. IPSCs were 3.5 0.9 nA (n 13) for wild-type cells and
3.5  0.8 nA (n  5) for Munc13-2 KO cells (Fig. 2 E and F).
Spontaneous miniature EPSC (mEPSC) frequenciesampli-
tudes and miniature inhibitory postsynaptic currents (mIPSC)
frequenciesamplitudes were also not affected by the Munc13-2
deletion (see examples in Fig. 2 D and G). mEPSC frequencies
amplitudes were 3.2  0.9 Hz22.7  2.4 pA (n  17) in
Munc13-2 KO cells and 3.8  0.7 Hz22.0  1.9 pA (n  23) in
wild-type cells. mIPSC frequenciesamplitudes were 2.8  0.9
Hz46  6 pA (n  4) in Munc13-2 KO cells and 2.1  0.4
Hz43.4 4.5 (n 13) in wild-type cells. In addition, the readily
releasable vesicle pool of Munc13-2 KO neurons was unchanged
as determined by application of hypertonic sucrose solution
(0.94  0.21 nC, n  10, for wild-type excitatory neurons vs.
0.93  0.14 nC, n  10, for Munc13-2 KO excitatory cells; Fig.
2C; data for inhibitory neurons not shown).
In contrast to the Munc13-2 KO, Munc13-1 deletion leads to
a 90% reduction of readily releasable vesicles and evoked
transmitter release (Fig. 2 A; ref. 3). This result indicates a partial
redundancy of Munc13 isoforms in hippocampal neurons. To
circumvent this redundancy, we generated Munc13-12 DKO
mice by interbreeding homozygous Munc13-2 KOs and het-
erozygous Munc13-1 KOs (3). Homozygous Munc13-2 KOs
from the same litters, which are indistinguishable from wild-type
(see above), served as control in all subsequent analyses. Ho-
mozygous Munc13-12 DKOs (E18) expressed neither
Munc13-1 nor Munc13-2 (Figs. 1D and 3), were very fragile, and
often were born dead. All DKOs that were born alive died within
1 h after birth. However, the brain and spinal cord from DKO
mice (E18) showed normal cell density and cytoarchitecture
(Fig. 4 A and B), and the expression levels of all tested synaptic
and nonsynaptic proteins (Munc13-3, Munc18-1, RIM, Rab3A,
Fig. 1. Mutation of the murine Munc13-2 gene. (A) Maps of the wild-type
Munc13-2 gene, the respective targeting vector, and the resulting mutant
gene. Positions of exons (black boxes) and restriction enzyme sites are indi-
cated. Hatched bar, Position of probe used for Southern. Neo, Neomycin
resistance gene; TK, thymidine kinase gene. (B) Southern blot analysis of the
Munc13-2 KO mutations in mice by using mouse tail DNA (EcoRI digest) from
the indicated Munc13-2 genotypes. (C) Munc13-2 protein expression in mice
of the indicated genotypes as determined by Western blotting using an
antibody that recognizes all Munc13-2 splice variants. (D) Expression of
Munc13-1 and Munc13-2 protein in mice of the indicated genotypes as de-
termined by Western blotting using an antibody to Munc13-1 (Upper) and an
antibody that recognizes all Munc13-2 splice variants (Lower).
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SNAP25, syntaxin 1A, synaptobrevin 2, complexin 12, and
tubulin) in Munc13-12 DKO brains were very similar to those
of wild-type animals (Fig. 3). Detection of subtle changes in
protein expression will require larger numbers of DKO mice,
which could not be generated so far.
Because of the perinatal lethality of the Munc13-12 DKOs,
we used primary hippocampal neurons from embryonic (E18)
Munc13-12 DKO and Munc13-2 KO littermates for functional
analyses. Munc13-12 DKO neurons developed a normal cell
morphology in culture (Fig. 4C). Whole cell recordings from
these neurons showed normal voltage-dependent Na, K, and
Ca2 currents (not shown). However, of a total of 45 recorded
Munc13-12 DKO neurons, none showed any sign of evoked or
spontaneous release at all times tested (8–15 DIV; Fig. 2), and
all recorded neurons were insensitive to application of hyper-
tonic sucrose solution (Fig. 2C), indicating a complete absence
of release-competent vesicles. Assuming that no deficit in syn-
aptogenesis contributes to the Munc13-12 DKO phenotype
(see below), these data lead to three important conclusions: (i)
Because release by hypertonic shock does not require Ca2
channel activity (15), the complete absence of spontaneous,
hypertonically induced, or evoked release in Munc13-12 DKO
cells indicates a complete loss of fusion competent vesicles. (ii)
Because all modes of vesicular release (spontaneous, action
potential evoked, and hypertonically evoked) are equally abol-
ished in Munc13-12 DKO cells, they seem to depend on the
same vesicular priming process and draw from the same pool of
release-competent, primed vesicles, indicating that hypertoni-
cally induced responses are a faithful measure of the pool of
fusion competent vesicles. (iii) No Munc13-independent vesicle-
priming pathways exist in mature hippocampal neurons in
culture. We know that inhibitory cells were equally affected by
the Munc13-12 DKO because strong stimulation of release by
-latrotoxin at the end of each experiment allowed the successful
induction of very rare mPSC events (see below) and, thus,
identification of transmitter phenotypes on the basis of mPSC
shape, amplitude, and pharmacology. Using this approach, 5 of
the 45 recorded cells were shown to be GABAergic.
Fig. 2. Complex functional redundancy of Munc13 isoforms. (A) Examples of
EPSCs recorded from cells of the indicated genotypes. (B) Mean EPSC ampli-
tudes measured in cells of the indicated genotypes. (C) Mean readily releas-
able vesicle pool sizes in cells of the indicated genotypes as estimated by the
charge integral measured after release induced by application of 500 mOsm
hypertonic sucrose solution for 4 s. (D) mEPSC activity recorded in cells of the
indicated genotypes. Holding potential 70 mV. (E) Examples of IPSCs re-
corded from cells of the indicated genotypes. Munc13-12 DKO inhibitory
neurons were identified after each experiment by detection of mIPSC events
induced by application of -latrotoxin. (F) Mean IPSC amplitudes measured in
cells of the indicated genotypes. (G) mIPSC activity recorded in cells of the
indicated genotypes. Pipette solution contained 140 mM KCl.
Fig. 3. Normal expression of synaptic proteins in Munc13-12 DKO brains.
Brain homogenates of the indicated genotypes were analyzed by Western
blotting using specific antibodies to the indicated proteins.









To test whether postsynaptic development is impaired in
Munc13-12 DKO cells, we used the spider toxin -latrotoxin,
which was shown to partially circumvent the need for Munc13-1 in
vesicular release (3). We found that application of 1 nM -latro-
toxin induced mEPSC and mIPSC activity in Munc13-12 DKO
neurons, but the release rate was much lower than that of wild-
type-like Munc13-2 KO control cells (Fig. 5 A–D). Five minutes
after a 60-s application of 1 nM -latrotoxin, Munc13-2 KO control
neurons exhibited mEPSCs at a frequency of 23.4  3.9 Hz (n 
17; Fig. 5 A and B). The average amplitude of mEPSCs was 22.7
2.4 pA (Fig. 5B). Both mEPSC amplitude and frequency after
-latrotoxin treatment are similar to wild-type values (not shown).
In contrast, Munc13-12 DKO neurons showed mEPSC-like events
after-latrotoxin treatment at a frequency of only 0.074 0.024 Hz
(n  17; Fig. 5 A and B). However, the amplitude of these rare
mEPSC events was similar to that observed in wild-type (3, 11) and
Munc13-2 KO neurons (25.6 2.6 pA, n 17; Fig. 5B). mIPSC-like
events in the presence of -latrotoxin were observed in five
Munc13-12 DKO cells at low frequency (0.14 0.07 Hz, n 5 vs.
15 5 Hz, n 4, in Munc13-2 KO cells) but with amplitudes (63
14 pA, n  5) comparable to wild-type-like Munc13-2 KO values
(45.5 6.3 pA, n 4; Fig. 5 C and D). These data and the fact that
detected mPSCs were blocked by the appropriate antagonists (Fig.
5 A and C) indicate that postsynaptic equipment with and accu-
mulation of functional -amino-3-hydroxy-5-methyl-4-isox-
azolepropionic acid (AMPA) or GABA receptors is not impaired.
Indeed, the localization of the glutamate receptor subunit GluR2 in
Munc13-12 DKO neurons was indistinguishable from control data
at the light microscopic level and concentrated in areas facing
synaptophysin-positive presynaptic terminals (not shown). More-
over, the overall cell surface density of receptors was normal in
Munc13-12 DKO neurons as determined by the responses of DKO
and control cells to 10 M kainate or 1 M GABA (Fig. 5E).
Density and Ultrastructure of Synapses in Munc13-12 DKO Neurons.
We next examined synapse density and ultrastructure in cultures
from Munc13-12 DKO and Munc13-2 KO control hippocampi.
The total number of synaptophysin-positive synapses per cell
(not shown) and the density of synapses per m2 of MAP-2-
positive dendrites were very similar in Munc13-2 KO control
(0.23  0.04 per m2, n  9 cells) and Munc13-12 DKO
neurons (0.29  0.02 per m2, n  10 cells) (Fig. 4C). Thus,
synapse formation in culture as determined by light microscopic
criteria is not altered on complete shut down of transmitter
release in Munc13-12 DKO neurons.
To detect effects of the loss of Munc13 priming factors or lack
of synaptic activity on synapse assembly, we analyzed the ultra-
structure of Munc13-12 DKO synapses. We observed typical
synaptic structures in Munc13-12 DKO neurons (Fig. 4D). In
particular, we found similar numbers of docked vesicles per
synapse in Munc13-2 KO (2.7  0.3, n  56 synapses) and
Munc13-12 DKO cells (2.1 0.2, n 62 synapses). The length
of active zones was larger in Munc13-12 DKO synapses (380 
27 nm, n  62) than in Munc13-2 KO control synapses (263 
19 nm, n  56; P  0.05). As a consequence, the number of
docked vesicles per m active zone was lower in Munc13-12
DKO synapses (5.9 0.8 per m, n 62) than in Munc13-2 KO
control synapses (9.2  0.8, n  56; P  0.05). Because of the
considerable variability of synaptic ultrastructure in culture,
these data have to be interpreted cautiously. Nevertheless, they
Fig. 4. Normal morphology of Munc13-12 DKO brains and cultured cells. (A) Nissl-stained sagittal section of brains from E18 mice of the indicated genotype.
(Bar  500 m.) (B) Nissl-stained coronal sections of spinal cord from E18 mice of the indicated genotype. (Bar  100 m.) (C) Cultured hippocampal neurons
from E18 mice of the indicated genotype (12 DIV) stained for the synapse specific marker synaptophysin. (Bar  10 m.) (D) Electron micrographs of synapses
of the indicated genotypes. (Bar  100 nm.)
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indicate that the striking phenotype of Munc13-12 DKO neu-
rons is not caused by a major dysfunction in synapse assembly,
and synapses assemble almost normally even in the complete
absence of spontaneous and evoked transmitter release.
Endocytosis in Munc13-12 DKO Neurons. To test whether the lack
of Munc13 priming factors and the resulting complete block of
synaptic release affect endocytosis, we assayed stimulation-
induced uptake of FM1-43 with quantitative fluorescence mi-
croscopy as a measure of synaptic endocytosis in cultured
neurons (6, 16–18). Munc13-2 KO neurons showed normal
FM1-43 stainingendocytosis (Fig. 6 Left). In contrast, Munc13-
12 DKO synapses were never stained in the presence of FM1-43
(Fig. 6 Right), indicating that DKO cells not only are unable to
exocytose but also lack Ca2-triggered endocytotic activity.
Assuming that Munc13s are not directly involved in endocytosis,
a notion that is supported by the rather normal ultrastructural
characteristics of Munc13-12 DKO synapses, these data indi-
cate that synaptic endocytosis is coupled to exocytosis and does
not take place when exocytosis is arrested.
Rescue of Munc13-12 DKO Synapses by Overexpression of Munc13-1
or Munc13-2. We next assayed the consequences of Semliki Forest
virus-mediated overexpression of Munc13-1 or Munc13-2 iso-
forms in Munc13-12 DKO neurons (9). Irrespective of the
Munc13 isoform used for overexpression, we obtained almost
complete rescue of synaptic amplitudes to wild-type like control
levels (i.e., levels measured in Munc13-2 KO littermates). EPSC
amplitudes of Munc13-2 KO neurons were 1.3 0.3 nA (n 17),
whereas Munc13-12 DKO neurons overexpressing either
Munc13-1 or Munc13-2 showed EPSC amplitudes of 0.84 0.14
nA (n  25) and 0.78  0.11 nA (n  32), respectively. Similar
rescue efficiencies were observed in inhibitory neurons. These
data show that the absence of Munc13 priming proteins is the
sole reason for the complete inability of double mutant synapses
to release transmitter. The fact that rescued EPSC amplitudes
approach wild-type levels irrespective of the overexpressed
Munc13 isoform suggests that all preformed synapses accept
both Munc13 isoforms as a priming factor. This result is remark-
able because, in wild-type neurons, 90% of all glutamatergic
synapses are exclusively dependent on Munc13-1 and do not
contain Munc13-2 (3).
Discussion
Munc13-1 deletion mutant neurons are characterized by a
dramatic reduction in readily releasable vesicle pools and evoked
transmitter secretion. Interestingly, this phenotype is specific for
glutamatergic neurons whereas GABAergic cells are completely
unaffected. Within a given Munc13-1-deficient glutamatergic
neuron, a large fraction of synapses is completely shut down
Fig. 5. Normal postsynaptic responsiveness in release-incompetent Munc 13-
12 double-deficient neurons. (A) Examples of mEPSC activity in cells of the
indicated genotypes after application of 1 nM -latrotoxin for 1 min. Note that
signals are blocked by 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f]quinoxaline
(NBQX). Stars indicate mEPSC events. (Inset) Individual mEPSC (expanded scale).
(B) Average mEPSC amplitude and frequency in cells of the indicated genotypes
after treatment with 1 nM -latrotoxin. (C) Examples of mIPSC activity in cells of
the indicated genotypes after application of 1 nM -latrotoxin for 1 min. Note
that signals are blocked by bicuculline. Stars indicate mIPSC events. Inset shows
individual mIPSC (expanded scale). (D) Average mIPSC amplitude and frequency
in cells of the indicated genotypes after treatment with 1 nM -latrotoxin. (E)
Mean peak current responses evoked by exogenous application of GABA and
kainate recorded from cells of the indicated genotypes.
Fig. 6. No endocytosis in release-incompetent Munc13-12 DKO neurons.
Localization of endocytotically active synapses by activity-dependent FM1-43
staining in cells of the indicated genotypes. Images show cells after staining
and wash. (Bar  10 m.)









whereas the remaining synapses release with normal probability
(3, 6). In contrast to Munc13-1, deletion of Munc13-3, the only
Munc13 isoform that is coexpressed with Munc13-1 in cerebel-
lum, has very mild phenotypic consequences that are not com-
patible with an essential role of Munc13-3 in GABAergic
synaptic vesicle priming (10). The present paper shows that the
same is true for Munc13-2 (Fig. 2).
The surprising lack of phenotypic alterations in Munc13-2 and
Munc13-3 KOs has led us to speculate that the specificity of
Munc13-1-mediated vesicle priming for glutamatergic synapses
is due to the fact that GABAergic neurons use a Munc13-
independent priming mechanism (3). We show now that this is
not the case in hippocampal neurons where the only two Munc13
isoforms present, Munc13-1 and Munc13-2, exhibit a complex
pattern of redundancy. In GABAergic hippocampal neurons, the
loss of Munc13-1 or Munc13-2 can be compensated for by the
presence of the respective other (Fig. 2 E and F) whereas, in
glutamatergic hippocampal neurons, Munc13-1 can compensate
for Munc13-2 loss but not vice versa (Fig. 2). In both cell types,
the complete absence of Munc13 priming factors leads to
elimination of readily releasable vesicles and total arrest of
synaptic vesicle priming (Fig. 2), demonstrating that Munc13-
mediated vesicle priming is a common and essential feature of
two different fast neurotransmitter systems and that no Munc13-
independent vesicle priming mechanisms exist in these mature
cells. Interestingly, recent data from adrenal chromaffin cells
suggest that Munc13s may also be involved in the priming of
catecholamine-containing chromaffin granules (19). Moreover,
release of acetylcholine and GABA in C. elegans is absolutely
dependent on the Munc13 homologue Unc-13 (5). We therefore
propose that Munc13-mediated vesicle priming is an essential
component of all fast neurotransmitter systems.
As mentioned above, most synapses in excitatory Munc13-1 KO
neurons are completely shut down whereas a small subpopulation
functions normally (3, 6). The fact that synaptic release activity in
Munc13-1-deficient neurons is completely abolished when
Munc13-2 is also deleted (Fig. 2) suggests that active synapses in
Munc13-1 KO neurons are exclusively driven by Munc13-2. Thus,
glutamatergic cells form two types of synapses that are differentially
equipped with Munc13-1 and Munc13-2. In contrast, Munc13-1 and
Munc13-2 are completely redundant in GABAergic hippocampal
neuron, suggesting that, in wild-type GABAergic neurons, all
synapses are equipped with both Munc13-1 and Munc13-2. FM1-43
imaging experiments (6) showed that the distribution of Munc13-
1-independent synapses does not follow a particular somatic or
dendritic localization pattern. Although it is possible that the
culture conditions conceal such morphological patterns, we suggest
that the heterogeneity of synapses is intrinsically present. Our view
is supported by data from in situ hybridization experiments and
semiquantitative immunoelectron microscopy studies showing that
only a subpopulation of type I presynaptic compartments formed by
Munc13-1-expressing cells contain Munc13-1 (20). Thus, glutama-
tergic neurons in situ likely express a similarly heterogeneous
synapse population with respect to Munc13 isoform content and
dependence. That individual axons in situ can indeed form func-
tionally different types of synapses is evident from experiments in
cortical (21, 22) and hippocampal (23) slices.
A particularly interesting conclusion from the present study is
that, even in the permanent and complete absence of sponta-
neous and evoked transmitter release in most areas of the central
nervous system (compensation by Munc13-3 is likely to occur
only in the cerebellum; ref. 10), brain and spinal cord develop
normally (Fig. 4 A and B). Moreover, release-incompetent
synapses in cultured hippocampal Munc13-12 DKO neurons
are formed and maintained at normal densities (Fig. 4C) and
have normal postsynaptic sensitivity characteristics (Fig. 5).
Finally, inactive Munc13-12 DKO synapses in culture have an
ultrastructural morphology that exhibits all classical features of
mature synapses and is only slightly altered in comparison with
wild-type-like control synapses (Fig. 4D). In that respect, our
study extends published data on Munc18-1-deficient mice in
which transmitter release is also completely shut down (24).
Synapses in Munc18-1-deficient brains are formed normally
during brain development but degenerate as the embryo ma-
tures. This result led to the conclusion that synaptic transmitter
release is not necessary for the initial formation of synapses but
essential for their maintenance (24). We found no evidence for
degenerative processes in release-incompetent Munc13-12
double-deficient brains. In particular, spinal cord and brainstem,
which more or less exclusively express Munc13-1 and Munc13-2
(8, 10), were intact (Fig. 4A). We conclude that synaptic activity
is not only dispensable for initial synaptogenesis (24) but also not
necessary for the basic maintenance of synapses and many of
their characteristics. The degeneration observed in Munc18-1-
deficient brains (24) may be due to the perturbation of a
Munc18-1-dependent process that is not directly related to
transmitter secretion.
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